Rights and permissions
About this article
Cite this article
Irbesartan inhibits the intravascular oxidative state in patients with coronary disease. Inpharma Wkly. 1319, 20 (2002). https://doi.org/10.2165/00128413-200213190-00041
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213190-00041